DDrare
Disease
Drug
Target Gene/Pathway
お問合せ先
EN
RAPAMUNE - 1 MG 100 COMPRESSE RIVESTITE IN BLISTER USO ORALE
( DrugBank: - / KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
2
筋萎縮性側索硬化症
1
2. 筋萎縮性側索硬化症
臨床試験数
:
645
/
薬物数
:
589
- (
DrugBank
:
163
) /
標的遺伝子数
:
150
-
標的パスウェイ数
:
225
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2016-002399-28-IT
(
EUCTR
)
14/07/2017
20170714
23/01/2018
20180123
Rapamycin (Sirolimus) treatment for amyotrophic lateral sclerosis
Rapamycin (Sirolimus) treatment for amyotrophic lateral sclerosis - RAP.ALS
definite or probable ALS
MedDRA version: 20.0;Level: PT;Classification code 10002026;Term: Amyotrophic lateral sclerosis;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
definite or probable ALS
MedDRA version: 20.0;Level: PT;Classification code 10002026;Term: Amyotroph ...
Trade Name:
RAPAMUNE - 1 MG 100 COMPRESSE RIVESTITE IN BLISTER USO ORALE
Product Name: Rapamune
AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA
NULL
Authorised-recruitment may be ongoing or finished
Female: yes
Male: yes
63
Phase 2
Italy